The global Viral Clearance Market generated revenue of USD 545 million in 2022 and is expected to reach USD 1,183.68 million in 2032, with a rapid revenue CAGR of 9% during the forecast period. The market's growth is driven by the increasing demand for biopharmaceuticals, advancements in technology, and the healthcare industry's growing awareness of the risks associated with viral infections....